Benitec Biopharma (BNTC) Institutional Ownership $10.30 -0.76 (-6.87%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Benitec Biopharma (NASDAQ:BNTC)CurrentInstitutional OwnershipPercentage52.19%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$73.25MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$223.25K Get BNTC Insider Trade Alerts Want to know when executives and insiders are buying or selling Benitec Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BNTC Institutional Buying and Selling by Quarter Benitec Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024Geode Capital Management LLC83,987$772K0.0%+31.3%0.795% 11/15/2024Janus Henderson Group PLC876,523$8.03M0.0%-2.7%8.300% 11/14/2024Suvretta Capital Management LLC8,829,053$81.14M2.6%+422.0%83.640% 11/14/2024Acuta Capital Partners LLC29,800$274K0.2%N/A0.282% 11/6/2024Simplify Asset Management Inc.116,535$1.07M0.0%+127.5%1.104% 10/7/2024 GAMMA Investing LLC6,540$60K0.0%+20.3%0.070% 8/20/2024Nantahala Capital Management LLC841,395$5.88M0.3%N/A8.982% 8/13/2024Simplify Asset Management Inc.51,216$358K0.0%N/A0.547% 7/2/2024 GAMMA Investing LLC5,438$38K0.0%+53.0%0.058% 5/16/2024Janus Henderson Group PLC244,491$1.27M0.0%+35.5%9.440% Get the Latest News and Ratings for BNTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter. 11/15/2023Adage Capital Partners GP L.L.C.189,188$572K0.0%N/A7.419% 11/15/2022Empery Asset Management LP796,837$296K1.8%N/A2.848% 11/15/2022Cantor Fitzgerald L. P.133,805$50K0.0%N/A0.478% 11/14/2022Armistice Capital LLC1,555,039$578K0.0%N/A6.025% 11/14/2022Altium Capital Management LP658,796$245K0.1%N/A2.552% 11/9/2021BlackRock Inc.19,974$71K0.0%-16.4%0.244% 8/16/2021State Street Corp21,000$89K0.0%N/A0.267% 8/13/2021Renaissance Technologies LLC42,700$181K0.0%N/A0.544% 8/13/2021Northern Trust Corp11,813$50K0.0%N/A0.150% 8/13/2021Geode Capital Management LLC34,493$146K0.0%+20.8%0.439% 8/13/2021Vanguard Group Inc.74,773$318K0.0%+43.3%0.952% 8/11/2021Bank of New York Mellon Corp14,932$63K0.0%-15.4%0.190% 7/31/2021Private Wealth Advisors LLC15,043$64K0.0%N/A0.192% 5/21/2021Citadel Advisors LLC23,253$120K0.0%N/A0.483% 5/19/2021Virtu Financial LLC22,520$116K0.0%+17.8%0.467% 5/18/2021Citadel Advisors LLC23,253$120K0.0%N/A0.483% 5/13/2021Bank of New York Mellon Corp17,653$91K0.0%N/A0.366% 5/12/2021Geode Capital Management LLC28,560$147K0.0%N/A0.593% 4/14/2021WealthTrust Axiom LLC12,950$66K0.0%N/A0.269% 4/12/2021HighPoint Advisor Group LLC93,000$462K0.1%N/A1.930% 3/4/2021Hudson Bay Capital Management LP107,995$324K0.0%N/A2.241% 2/24/2021Virtu Financial LLC19,114$57K0.0%N/A0.397% 2/16/2021Warberg Asset Management LLC10,000$30K0.0%N/A0.903% 2/10/2021Renaissance Technologies LLC50,660$152K0.0%N/A4.572% 11/13/2020Morgan Stanley34,838$219K0.0%+18.7%3.144% (Data available from 1/1/2016 forward) BNTC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BNTC shares? During the previous two years, the following institutional investors and hedge funds held shares of Benitec Biopharma shares: Suvretta Capital Management LLC ($81.14M), Janus Henderson Group PLC ($8.03M), Nantahala Capital Management LLC ($5.88M), Simplify Asset Management Inc. ($1.07M), Geode Capital Management LLC ($772K), Adage Capital Partners GP L.L.C. ($572K), and Acuta Capital Partners LLC ($274K).Learn more on BNTC's institutional investors. What percentage of Benitec Biopharma stock is owned by institutional investors? 52.19% of Benitec Biopharma stock is owned by institutional investors. Learn more on BNTC's institutional investor holdings. Which institutional investors have been buying Benitec Biopharma stock? The following institutional investors have purchased Benitec Biopharma stock in the last 24 months: Suvretta Capital Management LLC ($7.14M), Nantahala Capital Management LLC ($841.40K), Adage Capital Partners GP L.L.C. ($189.19K), Simplify Asset Management Inc. ($116.54K), Janus Henderson Group PLC ($64.09K), Acuta Capital Partners LLC ($29.80K), and Geode Capital Management LLC ($20.01K). How much institutional buying is happening at Benitec Biopharma? Institutional investors have bought a total of 8,401,771 shares in the last 24 months. This purchase volume represents approximately $73.82M in transactions. Which Benitec Biopharma major shareholders have been selling company stock? The following institutional investors have sold Benitec Biopharma stock in the last 24 months: Janus Henderson Group PLC ($24.29K). How much institutional selling is happening at Benitec Biopharma? Institutional investors have sold a total of 24,293 shares in the last 24 months. This volume of shares sold represents approximately $223.25K in transactions. Related Companies AVDL Major Shareholders BCYC Major Shareholders ZYME Major Shareholders NUVB Major Shareholders PSTX Major Shareholders COLL Major Shareholders GYRE Major Shareholders COGT Major Shareholders QURE Major Shareholders AVBP Major Shareholders This page (NASDAQ:BNTC) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Benitec Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Benitec Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNTC Stock Alerts